Shockwave Myocardial Revascularization System in Cinical Trial

Medispec of Germantown, MD is beginning a clinical trail for its Cardiospec system at three centers in the USA. Cardiospec uses Extracorporal Shockwaves coupled with R-wave ECG gating to stimulate angiogenesis in ischemic areas of myocardium. The procedure, called Extracorporeal Shockwave Myocardial Revascularization (ESMR), is non-invasive and may be provided in an inpatient or outpatient setting. ESMR therapy is designed to complement existing therapies for myocardial ischemia such as nitrates, CABG or angioplasty, and to provide an alternative treatment option for those patients who are candidates for more invasive procedures. Already available for clinical use in Canada, Medispec hopes to have FDA approval for Cardiospec by 2012.

Product page Cardiospec…
Product brochure… (.pdf)
UCSD press release: Non-Invasive Technology Evaluated to Treat Cardiac Chest Pain…